Funding · Seed · 22 September 2026
Dimension Biotechnologies raises £700k
Bristol-based Dimension Biotechnologies has raised £700k in a seed round. It builds a blood test that picks up early signs of kidney, heart and brain disease. It plans to scale up operations.
15thRound size percentile, 20 seed rounds
Press report
CompanyDimension Biotechnologies
StageSeed
SectorHealthTech
Based inBristol & South West
InvestorsNot named in the filing yet
SourcePress · confidence highView source ↗
Your note on Dimension Biotechnologies
Sign in to keep private notes on this company.
Is this your company?
Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.